Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023

EDMONTON, Alberta–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2023, on Thursday, May 4, 2023, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30 am ET that day to review these results and provide … [Read more…]

Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the acquisition of a lead placement solution from Radian, LLC that complements Axonics’ existing sacral neuromodulation (SNM) offering. Physicians determine a patient’s eligibility for long-term SNM therapy … [Read more…]

Forge Biologics Receives Qualified Person (QP) Declaration to Manufacture AAV Gene Therapies to Support European Clinical Programs

Forge fulfills European Medicines Agency’s (EMA) GMP manufacturing standards as determined by a QP audit and declaration to support clients intending to export gene therapy products for clinical programs in Europe COLUMBUS, Ohio–(BUSINESS WIRE)–Forge Biologics, a leading manufacturer of genetic medicines, today announced that its manufacturing facility has successfully completed the audits necessary and received … [Read more…]

First Coast Cardiovascular Institute Announces Partnership With Cardiovascular Logistics

JACKSONVILLE, Fla.–(BUSINESS WIRE)–First Coast Cardiovascular Institute (FCCI) announced today that it is partnering with national cardiology platform, Cardiovascular Logistics (CVL), to enhance and expand its cardiovascular care and services throughout Northern Florida & Southern Georgia. CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI will join a network of … [Read more…]

Curative Announces Spin-Off of Sensible Diagnostics with their Game-Changing 10-Minute Point-Of-Care PCR Testing Platform

Sensible Diagnostics Platform Allows Providers to Deliver Lab-Quality PCR Testing Results Economically and with Efficient Speed LOS ANGELES–(BUSINESS WIRE)–Curative Inc., a leading health services company that recently launched a new health plan out of Texas, announces the spin-off of Sensible Diagnostics, whose aim is to commercialize their groundbreaking point-of-care PCR testing platform. The new Sensible … [Read more…]

U.S. Medical Weight Loss Market Report 2023: Introduction of New Weight Loss Drugs Such as Wegovy, Ozempic and Saxenda Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The U.S. Medical Weight Loss Market” report from Marketdata LLC has been added to ResearchAndMarkets.com’s offering. The $8.8 billion U.S. medical weight loss market grew nearly 17% last year, recovering from the depressed levels of 2020-2021 during the pandemic. The tide has turned toward a greater focus on medical weight loss programs using … [Read more…]

Global Galectin Inhibitors Market Report 2023: Featuring BioXyTran, Galectin Therapeutics, HiFiBiO, PureTech Health & More – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Galectin Inhibitors Market Trends & Clinical Trials Insight 2023” report has been added to ResearchAndMarkets.com’s offering. Report Highlights: Global Galectin Inhibitors Clinical Pipeline By Company, Indication & Phase Insight On All 16 Galectin Inhibitors In Clinical Pipeline Clinical Study Initiation & Completion Timeline By Key Drugs Global Galectin Inhibitors Market Dynamics Insight … [Read more…]

MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease

LYON, France–(BUSINESS WIRE)–$MAAT–Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today reported that the U.S. Food and Drug Administration (FDA or the “Agency”) has lifted the clinical hold and cleared … [Read more…]

Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce it will host a symposium at the 3rd ISIET’s International Symposium on Inner Ear Therapeutics, an event sponsored by Sensorion, taking place on April 28-30, 2023, in Marrakech, Morocco. Members … [Read more…]

Syngenta and Biotalys Enter Into Strategic Partnership in Biologicals Innovation to Advance Solutions for Sustainable Agriculture

Syngenta to leverage Biotalys’ AGROBODY™ technology platform to expand insecticide biocontrol pipeline BASEL, Switzerland & GHENT, Belgium–(BUSINESS WIRE)–#Agriculture–Syngenta Crop Protection and Biotalys (Euronext – BTLS) today announced a collaboration to research, develop and commercialize new biocontrol solutions to manage key pests in a broad variety of crops. The new solution will be based on Biotalys’ … [Read more…]